Sergey Karakashev

1.3k citations
16 papers · 778 indexed · h-index 10
Topics
RNA modifications and cancer (5 papers)Cancer, Hypoxia, and Metabolism (5 papers)Cancer-related Molecular Pathways (4 papers)

In The Last Decade

Sergey Karakashev

16 papers receiving 776 citations

Peers

Sergey Karakashev
Comparison fields: 5 of 62
  • Molecular Biology 636
  • Oncology 270
  • Cancer Research 203
  • Pathology and Forensic Medicine 59
  • Reproductive Medicine 55
Replace Federica Guffanti with:
Federica Guffanti Italy
Benoît Thibault France
Junli Deng China
Blake W. Goodman United States
Tianbo Liu China
Marie Villedieu France
Vered Givant-Horwitz Norway
Ahrum Min South Korea
Shane W. O’Brien United States
Sergey Karakashev relative to Federica Guffanti Italy Federica Guffanti's profile →
Citations per field
00.5×1.5×2.4×
Federica Guffanti · 1×
Citations per year

Countries citing papers authored by Sergey Karakashev

Since Specialization
Citations

This map shows the geographic impact of Sergey Karakashev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Karakashev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Karakashev more than expected).

Fields of papers citing papers by Sergey Karakashev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Karakashev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Karakashev. The network helps show where Sergey Karakashev may publish in the future.

Co-authorship network of co-authors of Sergey Karakashev

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Karakashev. A scholar is included among the top collaborators of Sergey Karakashev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Karakashev. Sergey Karakashev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 9
3 37
4 17
5 97
6 5
7 1
8 141
9 76
10 77
11 134
12
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
1
13 82
14 40
15 1
16 59

About Sergey Karakashev

Sergey Karakashev is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 16 papers that have together received 778 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (203 citations), Oncology (270 citations) and Molecular Biology (636 citations). Sergey Karakashev has collaborated with scholars based in United States, Russia and France. Frequent co-authors include Mauricio J. Reginato, Rugang Zhang, Andrew V. Kossenkov, Nail Fatkhutdinov, Hengrui Zhu, Takeshi Fukumoto, Shuai Wu, Stéphanie Jean, Benjamin G. Bitler and David W. Speicher. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026